The Generic Gauntlet: Thriving in a Market of Paradoxes Welcome to the paradoxical world of generic pharmaceuticals. On one hand, […]

Introduction: More Than a Legal Hurdle, a Decisive Strategic Weapon In the world of pharmaceutical patent litigation, few events are

Introduction: The Collision of Two Worlds In the world of pharmaceuticals, the patent is more than a legal document; it

For decades, the generic business model was elegantly simple: wait for a blockbuster drug’s patent to expire, race to be

Beyond the Fortress: Reimagining Patents in an Era of Collaborative Innovation For generations, pharmaceutical companies have viewed their patent portfolios

The pharmaceutical landscape is, without a doubt, a dynamic and often bewildering domain. The headlines are consistently captured by the

Section 1: The U.S. Para IV Challenge as the Strategic Epicenter The strategic planning for generic drug entry into the

The Current Landscape: A Perfect storm of Pressure The contemporary life sciences landscape is characterized by a trio of intensifying

Litigation Summary and Analysis for GlaxoSmithKline LLC v. Sun Pharmaceutical Industries Ltd. | 1:25-cv-01170 Introduction The legal dispute between GlaxoSmithKline